From Sequence to System: Enhancing IVT mRNA Vaccine Effectiveness through Cutting-Edge Technologies

Area of Science:

• Biotechnology
• Vaccinology
• Molecular Medicine

Background:

• The COVID-19 pandemic highlighted the efficacy, safety, and rapid manufacturing of in vitro transcribed (IVT) mRNA vaccines.
• IVT mRNA technology is being explored for infectious diseases, cancers, and genetic disorders.
• Current IVT mRNA vaccines face limitations including low expression, off-target effects, instability, and immunogenicity.

Purpose of the Study:

• To provide a comprehensive review of current research and optimization strategies for IVT mRNA vaccines.
• To discuss advancements in IVT mRNA molecules and delivery systems.
• To explore the role of artificial intelligence (AI) in optimizing IVT mRNA technology.

Main Methods:

• Review of recent scientific literature on IVT mRNA vaccine development.
• Analysis of optimization strategies for mRNA molecules and delivery systems.
• Exploration of AI and deep learning applications in vaccine design and formulation.

Main Results:

• Significant progress has been made in enhancing IVT mRNA expression and stability.
• Novel delivery platforms like lipid nanoparticles (LNPs), polymers, and exosomes are improving targeted delivery and cellular uptake.
• AI models show potential for optimizing mRNA structure and delivery formulations.

Conclusions:

• Overcoming challenges in expression, targeting, stability, and immune response is critical for IVT mRNA vaccines.
• Advanced delivery systems and AI-driven design are crucial for realizing the therapeutic potential of IVT mRNA technology.
• Continued research and development are essential for the future of IVT mRNA vaccines in global health.